These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 152707)

  • 21. Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.
    Maciel RM; Miki SS; Nicolau W; Mendes NF
    J Clin Endocrinol Metab; 1976 Mar; 42(3):583-7. PubMed ID: 767355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic parameters of children with urinary tract infection: effects of trimethoprim-sulfamethoxazole.
    Wolfish NM; Wassef N; Gonzalez H; Acharya C
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):76-9. PubMed ID: 1079471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenytoin influence on human lymphocyte mitogen response: a prospective study of epileptic and nonepileptic patients.
    Gabourel JD; Davies GH; Bardana EJ; Ratzlaff NA
    Epilepsia; 1982 Aug; 23(4):367-76. PubMed ID: 7094904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy.
    Gilhus NE; Matre R; Aarli JA
    Int J Immunopharmacol; 1982; 4(1):43-8. PubMed ID: 6979523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T lymphocyte number and functions in paroxysmal nocturnal haemoglobinuria (PNH). A preliminary report.
    Hernández P; Cruz C; Fernández NL; León R; Ballester JM
    Haematologia (Budap); 1978-1979; 12(1-4):135-9. PubMed ID: 317060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of levamisole on the tuberculin test.
    Vanella LM; González Lascano AM; Míguez VM
    Allergol Immunopathol (Madr); 1981; 9(2):103-8. PubMed ID: 6794341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.
    Sorrell TC; Forbes IJ
    Clin Exp Immunol; 1975 May; 20(2):273-85. PubMed ID: 1212810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous reactions in head-injured patients receiving phenytoin for seizure prophylaxis.
    Rapp RP; Norton JA; Young B; Tibbs PA
    Neurosurgery; 1983 Sep; 13(3):272-5. PubMed ID: 6225961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of zinc on cellular immunity in chronic uremia.
    Antoniou LD; Shalhoub RJ; Schechter GP
    Am J Clin Nutr; 1981 Sep; 34(9):1912-7. PubMed ID: 7282617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic effects of TCDD exposure in humans.
    Knutsen AP
    Bull Environ Contam Toxicol; 1984 Dec; 33(6):673-81. PubMed ID: 6394071
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenytoin and formation of T lymphocyte rosettes.
    Neilan BA; Leppik IE
    Arch Neurol; 1980 Sep; 37(9):580-1. PubMed ID: 6968202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between cell-mediated immunity and clinical forms of paracoccidioidomycosis.
    Mota NG; Rezkallah-Iwasso MT; Peraçoli MT; Audi RC; Mendes RP; Marcondes J; Marques SA; Dillon NL; Franco MF
    Trans R Soc Trop Med Hyg; 1985; 79(6):765-72. PubMed ID: 3832489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective T cell function in atopic dermatitis.
    Rachelefsky GS; Opelz G; Mickey MR; Kiuchi M; Terasaki PI; Siegel SC; Stiehm ER
    J Allergy Clin Immunol; 1976 Jun; 57(6):569-76. PubMed ID: 1084358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Stricker RB; Goldberg B; Mills LB; Epstein WL
    J Am Acad Dermatol; 1995 Oct; 33(4):608-11. PubMed ID: 7673493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed cutaneous hypersensitivity reactions in patients with Kaposi's sarcoma.
    Taylor JF; Ziegler JL
    Br J Cancer; 1974 Oct; 30(4):312-8. PubMed ID: 4447775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular immunity in patients with meningococcal disease and in vaccinated subjects.
    Greenwood BM; Oduloju AJ; Ade-Serrano MA
    Clin Exp Immunol; 1979 Oct; 38(1):9-15. PubMed ID: 118835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.